Barington Line, Rummel Pia C, Lückmann Michael, Pihl Heidi, Larsen Olav, Daugvilaite Viktorija, Johnsen Anders H, Frimurer Thomas M, Karlshøj Stefanie, Rosenkilde Mette M
From the Department of Neuroscience and Pharmacology.
From the Department of Neuroscience and Pharmacology, the Novo Nordisk Foundation Center for Basic Metabolic Research, and.
J Biol Chem. 2016 Jul 29;291(31):16208-20. doi: 10.1074/jbc.M115.706747. Epub 2016 May 19.
Chemokine receptors play important roles in the immune system and are linked to several human diseases. The initial contact of chemokines with their receptors depends on highly specified extracellular receptor features. Here we investigate the importance of conserved extracellular disulfide bridges and aromatic residues in extracellular loop 2 (ECL-2) for ligand binding and activation in the chemokine receptor CCR8. We used inositol 1,4,5-trisphosphate accumulation and radioligand binding experiments to determine the impact of receptor mutagenesis on both chemokine and small molecule agonist and antagonist binding and action in CCR8. We find that the seven-transmembrane (TM) receptor conserved disulfide bridge (7TM bridge) linking transmembrane helix III (TMIII) and ECL-2 is crucial for chemokine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between the N terminus and TMVII is needed only for chemokines. Furthermore, we find that two distinct aromatic residues in ECL-2, Tyr(184) (Cys + 1) and Tyr(187) (Cys + 4), are crucial for binding of the CC chemokines CCL1 (agonist) and MC148 (antagonist), respectively, but not for small molecule binding. Finally, using in silico modeling, we predict an aromatic cluster of interaction partners for Tyr(187) in TMIV (Phe(171)) and TMV (Trp(194)). We show in vitro that these residues are crucial for the binding and action of MC148, thus supporting their participation in an aromatic cluster with Tyr(187) This aromatic cluster appears to be present in a large number of CC chemokine receptors and thereby could play a more general role to be exploited in future drug development targeting these receptors.
趋化因子受体在免疫系统中发挥着重要作用,并且与多种人类疾病相关。趋化因子与其受体的初始接触取决于高度特定的细胞外受体特征。在此,我们研究了趋化因子受体CCR8中细胞外环2(ECL-2)中保守的细胞外二硫键和芳香族残基对于配体结合和激活的重要性。我们使用肌醇1,4,5-三磷酸积累和放射性配体结合实验来确定受体诱变对CCR8中趋化因子以及小分子激动剂和拮抗剂结合及作用的影响。我们发现连接跨膜螺旋III(TMIII)和ECL-2的七跨膜(TM)受体保守二硫键(7TM桥)对于趋化因子和小分子作用至关重要,而N端与TMVII之间的趋化因子受体保守二硫键仅对趋化因子是必需的。此外,我们发现ECL-2中两个不同的芳香族残基,Tyr(184)(Cys + 1)和Tyr(187)(Cys + 4),分别对于CC趋化因子CCL1(激动剂)和MC148(拮抗剂)的结合至关重要,但对小分子结合并不重要。最后,通过计算机模拟,我们预测了TMIV(Phe(171))和TMV(Trp(194))中与Tyr(187)相互作用的芳香族残基簇。我们在体外表明这些残基对于MC148的结合和作用至关重要,从而支持它们与Tyr(187)参与形成芳香族残基簇。这种芳香族残基簇似乎存在于大量的CC趋化因子受体中,因此在未来针对这些受体的药物开发中可能发挥更普遍的作用。